PAHC

PHIBRO ANIMAL HEALTH CORP

PHIBRO ANIMAL HEALTH CORP (PAHC) has 4 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 2, 2026.

The most active filer is President and CEO BENDHEIM JACK with 9 filings. Insiders have net sold $3.0M over the trailing 6 months.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Jack Clifford Bendheim
  • Employees:2,475
  • HQ:Teaneck, NJ, US
  • IPO:2014-04-11

Insider Buying

$318K

reported purchases (SEC code P)

Insider Selling

$3.3M

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Source
CORCORAN E THOMASFirst filing
Purchase$318KJun 2SEC ↗
Sale$393KMay 7SEC ↗
Sale$404KMay 7SEC ↗
Sale$220KMay 7SEC ↗
Sale$394KApr 30SEC ↗
Sale$373KApr 30SEC ↗
Sale$371KApr 30SEC ↗
BENDHEIM JACKFirst filing
Sale$394KApr 23SEC ↗
BENDHEIM JACKFirst filing
Sale$382KApr 23SEC ↗
BENDHEIM JACKFirst filing
Sale$381KApr 23SEC ↗

Related companies

PHIBRO ANIMAL HEALTH CORP is in the Healthcare sector.